PLASMAFLOW™
Sequential Compression System
HCPCS: E0676
The PlasmaFlow is intended to be an easy to use sequential compression system, prescribed by a physician, for use in the home or clinical setting to help prevent the onset of DVT in patients by stimulating blood flow in the extremities (stimulating muscle contractions). This device can be used to:
• Aid in the prevention of DVT
• Enhance blood circulation
• Diminish post-operative pain and swelling
• Reduce wound healing time
• Aid in the treatment and healing of: stasis dermatitis, venous stasis ulcers, arterial and diabetic leg ulcers, chronic venous insufficiency and reduction of edema in the lower limbs
DESCRIPTION
The SpinalStim device has been approved by the FDA to be worn after cervical spine fusion surgery in patients at risk for non-fusion. For complete prescribing information, please refer to the Instruction Manual. This single-piece device is lightweight, flexible and portable, allowing freedom of movement during treatment. Typical prescribed treatment time is three hours per day. An LCD and audible alarm provide important feedback during treatment such as the operational status, treatment time remaining, battery capacity, etc.
Product Features:
Helps Prevent Onset of Deep Vein Thrombosis (DVT): PlasmaFlow helps prevent DVT, a leading factor for hospital readmission following major orthopedic surgery.
Provides Possible Alternative to Anticoagulants: PlasmaFlow offers physicians another option to help tailor preventative care to patient risk and provides an alternative for patients contraindicated for anticoagulants.
Provides Convenient Home Therapy: As hospital stays continue to shorten, PlasmaFlow provides a portable solution for patients to take home and keep. This allows facilities to offer mechanical DVT prophylaxis for the 2-3 weeks patients need it most, without the hassle of renting or servicing equipment.
Improves Patient Experience: PlasmaFlow enables patients to have the prophylaxis they need, in a simple, easy to use device without tubes or hoses.
Lowers Total Costs: Bundled payment of care initiatives are driving single payment for an orthopedic episode within 30-90 days of surgery, including costly DVT readmissions. By reducing DVT-related expenses and potentially reducing costs for anticoagulant regimes or compression device rental programs, PlasmaFlow helps reduce the total cost of the episode.